ID   R144B_HUMAN             Reviewed;         303 AA.
AC   Q7Z419; B3KUA8; B4DZI2; Q5TB85; Q6P4Q0; Q8N3R7; Q9BX38;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   10-MAY-2017, entry version 124.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF144B;
DE            EC=2.3.2.- {ECO:0000250|UniProtKB:O60260};
DE   AltName: Full=IBR domain-containing protein 2;
DE   AltName: Full=RING finger protein 144B;
DE   AltName: Full=p53-inducible RING finger protein;
GN   Name=RNF144B; Synonyms=IBRDC2, P53RFP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND INTERACTION WITH
RP   LCMT2.
RX   PubMed=12853982; DOI=10.1038/sj.onc.1206586;
RA   Ng C.-C., Arakawa H., Fukuda S., Kondoh H., Nakamura Y.;
RT   "p53RFP, a p53-inducible RING-finger protein, regulates the stability
RT   of p21WAF1.";
RL   Oncogene 22:4449-4458(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Prostate, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   TISSUE SPECIFICITY, AND INTERACTION WITH UBE2L3 AND UBE2L6.
RX   PubMed=16427630; DOI=10.1016/j.febslet.2005.09.105;
RA   Huang J., Xu L.-G., Liu T., Zhai Z., Shu H.-B.;
RT   "The p53-inducible E3 ubiquitin ligase p53RFP induces p53-dependent
RT   apoptosis.";
RL   FEBS Lett. 580:940-947(2006).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION
RP   WITH BAX.
RX   PubMed=20300062; DOI=10.1038/emboj.2010.39;
RA   Benard G., Neutzner A., Peng G., Wang C., Livak F., Youle R.J.,
RA   Karbowski M.;
RT   "IBRDC2, an IBR-type E3 ubiquitin ligase, is a regulatory factor for
RT   Bax and apoptosis activation.";
RL   EMBO J. 29:1458-1471(2010).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from
CC       E2 ubiquitin-conjugating enzymes UBE2L3 and UBE2L6 in the form of
CC       a thioester and then directly transfers the ubiquitin to targeted
CC       substrates such as LCMT2, thereby promoting their degradation.
CC       Induces apoptosis via a p53/TP53-dependent but caspase-independent
CC       mechanism. However, its overexpression also produces a decrease of
CC       the ubiquitin-dependent stability of BAX, a pro-apoptotic protein,
CC       ultimately leading to protection of cell death; But, it is not an
CC       anti-apoptotic protein per se. {ECO:0000269|PubMed:12853982,
CC       ECO:0000269|PubMed:20300062}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000250|UniProtKB:O60260}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with UBE2L3, UBE2L6 and LCMT2, as well as with
CC       BAX. {ECO:0000269|PubMed:12853982, ECO:0000269|PubMed:16427630,
CC       ECO:0000269|PubMed:20300062}.
CC   -!- INTERACTION:
CC       Q07812:BAX; NbExp=5; IntAct=EBI-2129982, EBI-516580;
CC       O14933:UBE2L6; NbExp=4; IntAct=EBI-2129982, EBI-2129974;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion membrane
CC       {ECO:0000269|PubMed:20300062}; Single-pass membrane protein
CC       {ECO:0000269|PubMed:20300062}. Cytoplasm
CC       {ECO:0000269|PubMed:20300062}. Note=Mostly cytosololic,
CC       accumulates in submitochondrial domains specifically upon
CC       apoptosis induction, in synchrony with BAX activation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q7Z419-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z419-2; Sequence=VSP_055853, VSP_055854;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Broadly expressed, with lowest levels in brain
CC       and thymus, and highest levels detectable in heart, ovary and
CC       testis. {ECO:0000269|PubMed:16427630,
CC       ECO:0000269|PubMed:20300062}.
CC   -!- DOMAIN: The RING-type zinc finger domain mediates binding to an E2
CC       ubiquitin-conjugating enzyme (By similarity). The transmembrane
CC       domain is essential for translocation to the mitochondria upon
CC       induction of apoptosis. {ECO:0000250}.
CC   -!- DOMAIN: Members of the RBR family are atypical E3 ligases. They
CC       interact with the E2 conjugating enzyme UBE2L3 and function like
CC       HECT-type E3 enzymes: they bind E2s via the first RING domain, but
CC       require an obligate trans-thiolation step during the ubiquitin
CC       transfer, requiring a conserved cysteine residue in the second
CC       RING domain. {ECO:0000250|UniProtKB:O60260}.
CC   -!- PTM: Auto-ubiquitinated.
CC   -!- SIMILARITY: Belongs to the RBR family. RNF144 subfamily.
CC       {ECO:0000305}.
CC   -!- CAUTION: Lacks the His residue in the RING-type domain 2 that is
CC       one of the conserved features of the family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD38622.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB076367; BAC02434.1; -; mRNA.
DR   EMBL; AK096832; BAG53370.1; -; mRNA.
DR   EMBL; AK302935; BAG64094.1; -; mRNA.
DR   EMBL; AL832329; CAD38622.1; ALT_INIT; mRNA.
DR   EMBL; AL138725; CAI15148.2; -; Genomic_DNA.
DR   EMBL; CH471087; EAW55407.1; -; Genomic_DNA.
DR   EMBL; BC063311; AAH63311.1; -; mRNA.
DR   CCDS; CCDS34345.1; -. [Q7Z419-1]
DR   RefSeq; NP_877434.2; NM_182757.3. [Q7Z419-1]
DR   UniGene; Hs.148741; -.
DR   ProteinModelPortal; Q7Z419; -.
DR   BioGrid; 129106; 16.
DR   DIP; DIP-43771N; -.
DR   IntAct; Q7Z419; 9.
DR   MINT; MINT-1771863; -.
DR   STRING; 9606.ENSP00000259939; -.
DR   PhosphoSitePlus; Q7Z419; -.
DR   BioMuta; RNF144B; -.
DR   DMDM; 57012811; -.
DR   PaxDb; Q7Z419; -.
DR   PeptideAtlas; Q7Z419; -.
DR   PRIDE; Q7Z419; -.
DR   DNASU; 255488; -.
DR   Ensembl; ENST00000259939; ENSP00000259939; ENSG00000137393. [Q7Z419-1]
DR   GeneID; 255488; -.
DR   KEGG; hsa:255488; -.
DR   UCSC; uc003ncs.3; human. [Q7Z419-1]
DR   CTD; 255488; -.
DR   DisGeNET; 255488; -.
DR   GeneCards; RNF144B; -.
DR   HGNC; HGNC:21578; RNF144B.
DR   HPA; CAB046013; -.
DR   HPA; HPA054127; -.
DR   HPA; HPA072469; -.
DR   neXtProt; NX_Q7Z419; -.
DR   OpenTargets; ENSG00000137393; -.
DR   PharmGKB; PA162401565; -.
DR   eggNOG; KOG1815; Eukaryota.
DR   eggNOG; ENOG410XP9Y; LUCA.
DR   GeneTree; ENSGT00840000129738; -.
DR   HOGENOM; HOG000007696; -.
DR   HOVERGEN; HBG052072; -.
DR   InParanoid; Q7Z419; -.
DR   KO; K11975; -.
DR   OMA; CRIYIER; -.
DR   OrthoDB; EOG091G0FQQ; -.
DR   PhylomeDB; Q7Z419; -.
DR   TreeFam; TF324777; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RNF144B; human.
DR   GenomeRNAi; 255488; -.
DR   PRO; PR:Q7Z419; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000137393; -.
DR   CleanEx; HS_RNF144B; -.
DR   Genevisible; Q7Z419; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031966; C:mitochondrial membrane; IDA:UniProtKB.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IBA:GO_Central.
DR   GO; GO:0031624; F:ubiquitin conjugating enzyme binding; IBA:GO_Central.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IBA:GO_Central.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0000209; P:protein polyubiquitination; IBA:GO_Central.
DR   GO; GO:0042787; P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR031127; E3_UB_ligase_RBR.
DR   InterPro; IPR002867; IBR_dom.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   PANTHER; PTHR11685; PTHR11685; 1.
DR   Pfam; PF01485; IBR; 2.
DR   SMART; SM00647; IBR; 2.
DR   SMART; SM00184; RING; 2.
DR   PROSITE; PS00518; ZF_RING_1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; Complete proteome; Cytoplasm;
KW   Membrane; Metal-binding; Mitochondrion; Reference proteome; Repeat;
KW   Transferase; Transmembrane; Transmembrane helix; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    303       E3 ubiquitin-protein ligase RNF144B.
FT                                /FTId=PRO_0000055911.
FT   TRANSMEM    258    278       Helical. {ECO:0000255}.
FT   ZN_FING      30     80       RING-type 1; atypical.
FT   ZN_FING     101    166       IBR-type.
FT   ZN_FING     193    222       RING-type 2; degenerate.
FT   ACT_SITE    206    206       {ECO:0000250|UniProtKB:Q9Y4X5}.
FT   VAR_SEQ       1     21       MGSAGRLHYLAMTAENPTPGD -> MLWITMPHPAHLGLFI
FT                                AVTLS (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055853.
FT   VAR_SEQ      22    110       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055854.
FT   CONFLICT    262    262       L -> P (in Ref. 3; CAD38622).
FT                                {ECO:0000305}.
FT   CONFLICT    275    275       Missing (in Ref. 6; AAH63311).
FT                                {ECO:0000305}.
SQ   SEQUENCE   303 AA;  33697 MW;  9FD505CDFB70B6A5 CRC64;
     MGSAGRLHYL AMTAENPTPG DLAPAPLITC KLCLCEQSLD KMTTLQECQC IFCTACLKQY
     MQLAIREGCG SPITCPDMVC LNHGTLQEAE IACLVPVDQF QLYQRLKFER EVHLDPYRTW
     CPVADCQTVC PVASSDPGQP VLVECPSCHL KFCSCCKDAW HAEVSCRDSQ PIVLPTEHRA
     LFGTDAEAPI KQCPVCRVYI ERNEGCAQMM CKNCKHTFCW YCLQNLDNDI FLRHYDKGPC
     RNKLGHSRAS VMWNRTQVVG ILVGLGIIAL VTSPLLLLAS PCIICCVCKS CRGKKKKHDP
     STT
//
